{"id":772339,"date":"2023-07-25T14:44:41","date_gmt":"2023-07-25T18:44:41","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/btai-lawsuit-alert-levi-korsinsky-notifies-bioxcel-therapeutics-inc-investors-of-a-class-action-lawsuit-and-upcoming-deadline-3\/"},"modified":"2023-07-25T14:44:41","modified_gmt":"2023-07-25T18:44:41","slug":"btai-lawsuit-alert-levi-korsinsky-notifies-bioxcel-therapeutics-inc-investors-of-a-class-action-lawsuit-and-upcoming-deadline-3","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/btai-lawsuit-alert-levi-korsinsky-notifies-bioxcel-therapeutics-inc-investors-of-a-class-action-lawsuit-and-upcoming-deadline-3\/","title":{"rendered":"BTAI\u00a0LAWSUIT ALERT: Levi &amp;\u00a0Korsinsky Notifies BioXcel Therapeutics, Inc.\u00a0Investors of a Class Action Lawsuit and Upcoming Deadline"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"justify\">NEW YORK, July  25, 2023  (GLOBE NEWSWIRE) &#8212; Levi &amp; Korsinsky, LLP notifies investors in <strong>BioXcel Therapeutics, Inc.<\/strong> (&#8220;BioXcel&#8221; or the &#8220;Company&#8221;) (NASDAQ: BTAI) of a class action securities lawsuit.<\/p>\n<p>\n        <strong>CLASS DEFINITION: <\/strong>The lawsuit seeks to recover losses on behalf of BioXcel investors who were adversely affected by alleged securities fraud between December 15, 2021 and June 28, 2023. Follow the link below to get more information and be contacted by a member of our team:<\/p>\n<p align=\"center\">\n        <a href=\"https:\/\/zlk.com\/pslra-1\/bioxcel-lawsuit-submission-form?prid=42536&amp;wire=3\" rel=\"nofollow noopener\" target=\"_blank\">https:\/\/zlk.com\/pslra-1\/bioxcel-lawsuit-submission-form?prid=42536&amp;wire=3<\/a>\n      <\/p>\n<p>\n        <strong>BTAI<\/strong> investors may also contact Joseph E. Levi, Esq. via email at\u00a0jlevi@levikorsinsky.com\u00a0or by telephone at (212) 363-7500.<\/p>\n<p>\n        <strong>CASE DETAILS: <\/strong>The filed complaint alleges that defendants made false statements and\/or concealed that: (1) the Company lacked adequate internal controls over protocol adherence and data integrity; (2) as a result, the Company\u2019s principal investigator failed to adhere to the informed consent form approved by the Institutional Review Board; (3) the Company\u2019s principal investigator failed to maintain adequate case histories for certain patients whose records were reviewed by the FDA; (4) the Company\u2019s principal investigator fabricated email correspondence with a pharmacovigilance safety vendor that was then provided to the FDA; (5) the foregoing would negatively impact the Company\u2019s ability to obtain regulatory approval of BXCL501 for the treatment of agitation associated with dementia in patients with probable Alzheimer\u2019s disease; and (6) as a result of the foregoing, defendants\u2019 positive statements about the Company\u2019s business, operations, and prospects were materially misleading and\/or lacked a reasonable basis.<\/p>\n<p>\n        <strong>WHAT&#8217;S NEXT? <\/strong>If you suffered a loss in BioXcel during the relevant time frame, you have until <strong>September 5, 2023<\/strong>\u00a0to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn&#8217;t require that you serve as a lead plaintiff.<\/p>\n<p>\n        <strong>NO COST TO YOU: <\/strong>If you are a class member, you may be entitled to compensation without payment of any out-of-pocket costs or fees. <strong>There is no cost or obligation to participate.<\/strong><\/p>\n<p>\n        <strong>WHY LEVI &amp; KORSINSKY: <\/strong>Over the past 20 years, the team at Levi &amp; Korsinsky has secured hundreds of millions of dollars for aggrieved shareholders and built a track record of winning high-stakes cases. Our firm has extensive expertise representing investors in complex securities litigation and a team of over 70 employees to serve our clients. For seven years in a row, Levi &amp; Korsinsky has ranked in ISS Securities Class Action Services\u2019 Top 50 Report as one of the top securities litigation firms in the United States.<\/p>\n<p>\n        <strong>CONTACT:<\/strong><br \/>\n        <br \/>Levi &amp; Korsinsky, LLP <br \/>Joseph E. Levi, Esq.<br \/>Ed Korsinsky, Esq.<br \/>55 Broadway, 4th Floor Suite #427<br \/>New York, NY 10006<br \/>jlevi@levikorsinsky.com<br \/>Tel: (212) 363-7500<br \/>Fax: (212) 363-7171<br \/>www.zlk.com<\/p>\n<p \/>\n      <img decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODg4MDU5MyM1NzA4NzE4IzIwMjA0MjY=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" src=\"https:\/\/ml.globenewswire.com\/media\/OThiMzNjYmEtYmFlNi00MTdhLWI2MDUtNjZmZDMzNGMyYjU1LTEwMzIyOTM=\/tiny\/Levi-Korsinsky-LLP.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>NEW YORK, July 25, 2023 (GLOBE NEWSWIRE) &#8212; Levi &amp; Korsinsky, LLP notifies investors in BioXcel Therapeutics, Inc. (&#8220;BioXcel&#8221; or the &#8220;Company&#8221;) (NASDAQ: BTAI) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of BioXcel investors who were adversely affected by alleged securities fraud between December 15, 2021 and June 28, 2023. Follow the link below to get more information and be contacted by a member of our team: https:\/\/zlk.com\/pslra-1\/bioxcel-lawsuit-submission-form?prid=42536&amp;wire=3 BTAI investors may also contact Joseph E. Levi, Esq. via email at\u00a0jlevi@levikorsinsky.com\u00a0or by telephone at (212) 363-7500. CASE DETAILS: The filed complaint alleges that defendants made false statements and\/or concealed that: (1) the Company lacked adequate internal controls over protocol adherence and data &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/btai-lawsuit-alert-levi-korsinsky-notifies-bioxcel-therapeutics-inc-investors-of-a-class-action-lawsuit-and-upcoming-deadline-3\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;BTAI\u00a0LAWSUIT ALERT: Levi &amp;\u00a0Korsinsky Notifies BioXcel Therapeutics, Inc.\u00a0Investors of a Class Action Lawsuit and Upcoming Deadline&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-772339","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>BTAI\u00a0LAWSUIT ALERT: Levi &amp;\u00a0Korsinsky Notifies BioXcel Therapeutics, Inc.\u00a0Investors of a Class Action Lawsuit and Upcoming Deadline - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/btai-lawsuit-alert-levi-korsinsky-notifies-bioxcel-therapeutics-inc-investors-of-a-class-action-lawsuit-and-upcoming-deadline-3\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"BTAI\u00a0LAWSUIT ALERT: Levi &amp;\u00a0Korsinsky Notifies BioXcel Therapeutics, Inc.\u00a0Investors of a Class Action Lawsuit and Upcoming Deadline - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"NEW YORK, July 25, 2023 (GLOBE NEWSWIRE) &#8212; Levi &amp; Korsinsky, LLP notifies investors in BioXcel Therapeutics, Inc. (&#8220;BioXcel&#8221; or the &#8220;Company&#8221;) (NASDAQ: BTAI) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of BioXcel investors who were adversely affected by alleged securities fraud between December 15, 2021 and June 28, 2023. Follow the link below to get more information and be contacted by a member of our team: https:\/\/zlk.com\/pslra-1\/bioxcel-lawsuit-submission-form?prid=42536&amp;wire=3 BTAI investors may also contact Joseph E. Levi, Esq. via email at\u00a0jlevi@levikorsinsky.com\u00a0or by telephone at (212) 363-7500. CASE DETAILS: The filed complaint alleges that defendants made false statements and\/or concealed that: (1) the Company lacked adequate internal controls over protocol adherence and data &hellip; Continue reading &quot;BTAI\u00a0LAWSUIT ALERT: Levi &amp;\u00a0Korsinsky Notifies BioXcel Therapeutics, Inc.\u00a0Investors of a Class Action Lawsuit and Upcoming Deadline&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/btai-lawsuit-alert-levi-korsinsky-notifies-bioxcel-therapeutics-inc-investors-of-a-class-action-lawsuit-and-upcoming-deadline-3\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2023-07-25T18:44:41+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODg4MDU5MyM1NzA4NzE4IzIwMjA0MjY=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/btai-lawsuit-alert-levi-korsinsky-notifies-bioxcel-therapeutics-inc-investors-of-a-class-action-lawsuit-and-upcoming-deadline-3\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/btai-lawsuit-alert-levi-korsinsky-notifies-bioxcel-therapeutics-inc-investors-of-a-class-action-lawsuit-and-upcoming-deadline-3\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"BTAI\u00a0LAWSUIT ALERT: Levi &amp;\u00a0Korsinsky Notifies BioXcel Therapeutics, Inc.\u00a0Investors of a Class Action Lawsuit and Upcoming Deadline\",\"datePublished\":\"2023-07-25T18:44:41+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/btai-lawsuit-alert-levi-korsinsky-notifies-bioxcel-therapeutics-inc-investors-of-a-class-action-lawsuit-and-upcoming-deadline-3\\\/\"},\"wordCount\":453,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/btai-lawsuit-alert-levi-korsinsky-notifies-bioxcel-therapeutics-inc-investors-of-a-class-action-lawsuit-and-upcoming-deadline-3\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODg4MDU5MyM1NzA4NzE4IzIwMjA0MjY=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/btai-lawsuit-alert-levi-korsinsky-notifies-bioxcel-therapeutics-inc-investors-of-a-class-action-lawsuit-and-upcoming-deadline-3\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/btai-lawsuit-alert-levi-korsinsky-notifies-bioxcel-therapeutics-inc-investors-of-a-class-action-lawsuit-and-upcoming-deadline-3\\\/\",\"name\":\"BTAI\u00a0LAWSUIT ALERT: Levi &amp;\u00a0Korsinsky Notifies BioXcel Therapeutics, Inc.\u00a0Investors of a Class Action Lawsuit and Upcoming Deadline - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/btai-lawsuit-alert-levi-korsinsky-notifies-bioxcel-therapeutics-inc-investors-of-a-class-action-lawsuit-and-upcoming-deadline-3\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/btai-lawsuit-alert-levi-korsinsky-notifies-bioxcel-therapeutics-inc-investors-of-a-class-action-lawsuit-and-upcoming-deadline-3\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODg4MDU5MyM1NzA4NzE4IzIwMjA0MjY=\",\"datePublished\":\"2023-07-25T18:44:41+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/btai-lawsuit-alert-levi-korsinsky-notifies-bioxcel-therapeutics-inc-investors-of-a-class-action-lawsuit-and-upcoming-deadline-3\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/btai-lawsuit-alert-levi-korsinsky-notifies-bioxcel-therapeutics-inc-investors-of-a-class-action-lawsuit-and-upcoming-deadline-3\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/btai-lawsuit-alert-levi-korsinsky-notifies-bioxcel-therapeutics-inc-investors-of-a-class-action-lawsuit-and-upcoming-deadline-3\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODg4MDU5MyM1NzA4NzE4IzIwMjA0MjY=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODg4MDU5MyM1NzA4NzE4IzIwMjA0MjY=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/btai-lawsuit-alert-levi-korsinsky-notifies-bioxcel-therapeutics-inc-investors-of-a-class-action-lawsuit-and-upcoming-deadline-3\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"BTAI\u00a0LAWSUIT ALERT: Levi &amp;\u00a0Korsinsky Notifies BioXcel Therapeutics, Inc.\u00a0Investors of a Class Action Lawsuit and Upcoming Deadline\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"BTAI\u00a0LAWSUIT ALERT: Levi &amp;\u00a0Korsinsky Notifies BioXcel Therapeutics, Inc.\u00a0Investors of a Class Action Lawsuit and Upcoming Deadline - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/btai-lawsuit-alert-levi-korsinsky-notifies-bioxcel-therapeutics-inc-investors-of-a-class-action-lawsuit-and-upcoming-deadline-3\/","og_locale":"en_US","og_type":"article","og_title":"BTAI\u00a0LAWSUIT ALERT: Levi &amp;\u00a0Korsinsky Notifies BioXcel Therapeutics, Inc.\u00a0Investors of a Class Action Lawsuit and Upcoming Deadline - Market Newsdesk","og_description":"NEW YORK, July 25, 2023 (GLOBE NEWSWIRE) &#8212; Levi &amp; Korsinsky, LLP notifies investors in BioXcel Therapeutics, Inc. (&#8220;BioXcel&#8221; or the &#8220;Company&#8221;) (NASDAQ: BTAI) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of BioXcel investors who were adversely affected by alleged securities fraud between December 15, 2021 and June 28, 2023. Follow the link below to get more information and be contacted by a member of our team: https:\/\/zlk.com\/pslra-1\/bioxcel-lawsuit-submission-form?prid=42536&amp;wire=3 BTAI investors may also contact Joseph E. Levi, Esq. via email at\u00a0jlevi@levikorsinsky.com\u00a0or by telephone at (212) 363-7500. CASE DETAILS: The filed complaint alleges that defendants made false statements and\/or concealed that: (1) the Company lacked adequate internal controls over protocol adherence and data &hellip; Continue reading \"BTAI\u00a0LAWSUIT ALERT: Levi &amp;\u00a0Korsinsky Notifies BioXcel Therapeutics, Inc.\u00a0Investors of a Class Action Lawsuit and Upcoming Deadline\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/btai-lawsuit-alert-levi-korsinsky-notifies-bioxcel-therapeutics-inc-investors-of-a-class-action-lawsuit-and-upcoming-deadline-3\/","og_site_name":"Market Newsdesk","article_published_time":"2023-07-25T18:44:41+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODg4MDU5MyM1NzA4NzE4IzIwMjA0MjY=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/btai-lawsuit-alert-levi-korsinsky-notifies-bioxcel-therapeutics-inc-investors-of-a-class-action-lawsuit-and-upcoming-deadline-3\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/btai-lawsuit-alert-levi-korsinsky-notifies-bioxcel-therapeutics-inc-investors-of-a-class-action-lawsuit-and-upcoming-deadline-3\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"BTAI\u00a0LAWSUIT ALERT: Levi &amp;\u00a0Korsinsky Notifies BioXcel Therapeutics, Inc.\u00a0Investors of a Class Action Lawsuit and Upcoming Deadline","datePublished":"2023-07-25T18:44:41+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/btai-lawsuit-alert-levi-korsinsky-notifies-bioxcel-therapeutics-inc-investors-of-a-class-action-lawsuit-and-upcoming-deadline-3\/"},"wordCount":453,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/btai-lawsuit-alert-levi-korsinsky-notifies-bioxcel-therapeutics-inc-investors-of-a-class-action-lawsuit-and-upcoming-deadline-3\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODg4MDU5MyM1NzA4NzE4IzIwMjA0MjY=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/btai-lawsuit-alert-levi-korsinsky-notifies-bioxcel-therapeutics-inc-investors-of-a-class-action-lawsuit-and-upcoming-deadline-3\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/btai-lawsuit-alert-levi-korsinsky-notifies-bioxcel-therapeutics-inc-investors-of-a-class-action-lawsuit-and-upcoming-deadline-3\/","name":"BTAI\u00a0LAWSUIT ALERT: Levi &amp;\u00a0Korsinsky Notifies BioXcel Therapeutics, Inc.\u00a0Investors of a Class Action Lawsuit and Upcoming Deadline - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/btai-lawsuit-alert-levi-korsinsky-notifies-bioxcel-therapeutics-inc-investors-of-a-class-action-lawsuit-and-upcoming-deadline-3\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/btai-lawsuit-alert-levi-korsinsky-notifies-bioxcel-therapeutics-inc-investors-of-a-class-action-lawsuit-and-upcoming-deadline-3\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODg4MDU5MyM1NzA4NzE4IzIwMjA0MjY=","datePublished":"2023-07-25T18:44:41+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/btai-lawsuit-alert-levi-korsinsky-notifies-bioxcel-therapeutics-inc-investors-of-a-class-action-lawsuit-and-upcoming-deadline-3\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/btai-lawsuit-alert-levi-korsinsky-notifies-bioxcel-therapeutics-inc-investors-of-a-class-action-lawsuit-and-upcoming-deadline-3\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/btai-lawsuit-alert-levi-korsinsky-notifies-bioxcel-therapeutics-inc-investors-of-a-class-action-lawsuit-and-upcoming-deadline-3\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODg4MDU5MyM1NzA4NzE4IzIwMjA0MjY=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODg4MDU5MyM1NzA4NzE4IzIwMjA0MjY="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/btai-lawsuit-alert-levi-korsinsky-notifies-bioxcel-therapeutics-inc-investors-of-a-class-action-lawsuit-and-upcoming-deadline-3\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"BTAI\u00a0LAWSUIT ALERT: Levi &amp;\u00a0Korsinsky Notifies BioXcel Therapeutics, Inc.\u00a0Investors of a Class Action Lawsuit and Upcoming Deadline"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/772339","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=772339"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/772339\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=772339"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=772339"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=772339"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}